ERK1/2 inhibitors act as monovalent degraders inducing ubiquitylation and proteasome-dependent turnover of ERK2, but not ERK1. (2023)

First Author: Balmanno K
Attributed to:  New tools and technology to evaluate biological sulphation funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1042/bcj20220598

PubMed Identifier: 37018014

Publication URI: http://europepmc.org/abstract/MED/37018014

Type: Journal Article/Review

Volume: 480

Parent Publication: The Biochemical journal

Issue: 9

ISSN: 0264-6021